UFF
CORT icon

USA Financial Formulas’s Corcept Therapeutics CORT Stock Holding History

USA Financial Formulas’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-767
Closed -$56.3K – 269
2025
Q2 		$56.3K Buy
+767
New +$55.6K 0.01% 201
2025
Q1 		– Sell
-1,065
Closed -$53.7K – 297
2024
Q4 		$53.7K Buy
+1,065
New +$55.8K 0.01% 235
2021
Q1 		– Sell
-2,401
Closed -$63K – 353
2020
Q4 		$63K Buy
+2,401
New +$50.6K 0.05% 169
2020
Q3 		– Sell
-17,606
Closed -$296K – 330
2020
Q2 		$296K Buy
+17,606
New +$247K 0.22% 67
2017
Q4 		– Sell
-34,091
Closed -$658K – 275
2017
Q3 		$658K Buy
+34,091
New +$508K 0.16% 119
2017
Q1 		– Sell
-38,601
Closed -$280K – 257
2016
Q4 		$280K Buy
+38,601
New +$302K 0.07% 198

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return